ITASCA,
Ill., Nov. 25, 2024 /PRNewswire/ -- Lakeside
Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a
U.S.-based integrated cross-border supply chain solution provider
with a strategic focus on the Asian market operating under the
brand American Bear Logistics ("ABL"), announces that Hupan
Pharmaceutical (Hubei) Co., Ltd.
("Hupan Pharmaceutical"), a company recently acquired by Lakeside,
has established partnership with Sinopharm Group Hubei Co.,
Ltd. ("Sinopharm Hubei"). Sinopharm Hubei is a subsidiary of
Sinopharm Group Co., Ltd., a leader in China's pharmaceutical industry. This
partnership for essential medicine storage, transportation, and
logistics services positions Lakeside for accelerated growth and
solidifies its foothold in China's
medical logistics sector.
Hupan Pharmaceutical's partnership with Sinopharm Hubei
underscores the growing demand for specialized logistics and
supply chain solutions in China's
healthcare market. Through this partnership, Hupan Pharmaceutical
will support Sinopharm Hubei's comprehensive pharmaceutical
distribution needs, ensuring high standards in storing and
transporting pharmaceutical products, including refrigerated and
frozen medications, peptide hormones, and other essential medical
supplies. This partnership showcases Hupan
Pharmaceutical's trusted expertise in the complex clinical supply
requirements in oncology, antibiotics, large-volume infusions, and
aesthetic medicine.
The acquisition of Hupan Pharmaceutical is anticipated to
contribute approximately $7 million
in annual revenues for Lakeside. The partnership with Sinopharm
Hubei reinforces Lakeside's expanding presence,
unlocks new revenue streams, and strengthens its
capability to provide high-quality logistics solutions tailored for
China's healthcare market. With
Lakeside's strategic and technological strengths combined with
Hupan Pharmaceutical's established service network, the Company is
poised to meet the rising demands of China's pharmaceutical logistics sector.
Henry Liu, Chairman & CEO of
Lakeside, commented: "Our recent acquisition of Hupan
Pharmaceutical and the resulting partnerships with an industry
leader like Sinopharm mark a new chapter of growth for Lakeside. We
are dedicated to leveraging these relationships to deliver
exceptional value in pharmaceutical logistics, strengthening our
position within China's healthcare
industry. Sinopharm's trust in Hupan's capabilities is a testament
to the quality of our solutions and our commitment to expanding our
presence in critical and emerging markets."
About Lakeside Holding Limited
Lakeside Holding Limited, based in Itasca, IL, is a
U.S.-based integrated cross-border supply chain solution provider
with a strategic focus on the Asian market,
including China and South Korea. Operating under the
brand American Bear Logistics, we primarily provide customized
cross-border ocean freight solutions and airfreight solutions in
the U.S. that specifically cater to our customer's requirements and
needs in transporting goods into the U.S. We are an Asian
American-owned business rooted in the U.S. with in-depth
understanding of both the U.S. and Asian international trading and
logistics service markets. Our customers are typically Asia-
and U.S.-based logistics service companies serving large e-commerce
platforms, social commerce platforms, and manufacturers to sell and
transport consumer and industrial goods made in Asia into
the U.S. For more information, please
visit https://lakeside-holding.com.
Safe Harbor Statement
This press release contains forward-looking statements that
reflect our current expectations and views of future events. Known
and unknown risks, uncertainties and other factors may cause our
actual results, performance or achievements to be materially
different from those expressed or implied by the forward-looking
statements. You can identify some of these forward-looking
statements by words or phrases such as "may," "will," "expect,"
"anticipate," "aim," "estimate," "intend," "plan," "believe,"
"is/are likely to," "potential," "continue" or other similar
expressions. We have based these forward-looking statements largely
on our current expectations and projections about future events
that we believe may affect our financial condition, results of
operations, business strategy and financial needs. These
forward-looking statements involve various risks and uncertainties.
Except as required by law, we undertake no obligation to update or
revise publicly any forward-looking statements, whether as a result
of new information, future events or otherwise, after the date on
which the statements are made or to reflect the occurrence of
unanticipated events. We qualify all of our forward-looking
statements by these cautionary statements.
Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com
View original
content:https://www.prnewswire.com/news-releases/lakeside-strengthens-market-position-in-chinas-pharmaceutical-logistics-with-key-sinopharmhubei-contracts-302314860.html
SOURCE Lakeside Holding Limited
